On the Frontlines of Metastatic Breast Cancer
Stay up to date on the latest advancements with our exclusive podcast series, On the Frontlines of Metastatic Breast Cancer. Tune in to hear from leading experts as they explore key diagnosis and treatment strategies in addition to the ongoing research that’s dedicated to the fight against this disease.
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast CancerHow Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS
Marie Wood, MD
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast CancerMCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS
Marie Wood, MD
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerRethinking Frontline Care in HER2- Metastatic Breast Cancer
Alexandria May, PharmD, BCPS
Tiffany Traina, MD, FASCO
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerProtecting Heart Health in Metastatic Breast Cancer
Ryan Quigley
Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerThe Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley
Gregory Vidal, MD, PhD
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Care for Men with Breast Cancer
Jose Pablo Leone, MD
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerDecoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast CancerAddressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP
Alexis Ann LeVee, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerBiomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD
Ryan Quigley
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast CancerHER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP
Heather Parsons
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast CancerHow ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerExploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast CancerDESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerModern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerTracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
- advertisement
